This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Unibioscreen S.a., Université Libre De Bruxelles. Active years: 2008-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Uccle, BE (2008)
- Waterloo, BE (2010 - 2011)
Company Filing History:
3 out of 3 
1 out of 99 
Years Active: 2008-2011
Title: The Innovative Contributions of Francis Darro
Introduction
Francis Darro is a notable inventor based in Waterloo, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment. With a total of 3 patents, his work has the potential to impact the medical community positively.
Latest Patents
Darro's latest patents include the invention of 2″ oxo-voruscharin and derivatives thereof. This patent discloses compounds and pharmaceutical compositions that are useful in methods of treating cancer, especially pancreatic cancer. Another significant patent involves azonafide derivatives, which are obtained by reacting azonafide with various chemical agents. These derivatives serve as active ingredients in pharmaceutical compositions aimed at preventing and treating cell proliferative disorders, particularly several forms of cancer.
Career Highlights
Throughout his career, Darro has worked with reputable organizations such as Unibioscreen S.A. and Université Libre de Bruxelles. His experience in these institutions has allowed him to refine his research and contribute to innovative solutions in the pharmaceutical industry.
Collaborations
Some of his notable coworkers include Eric Van Quaquebeke and Robert Kiss. Their collaborative efforts have further advanced the research and development of pharmaceutical compounds.
Conclusion
Francis Darro's contributions to the field of pharmaceuticals through his innovative patents highlight his commitment to improving cancer treatment. His work continues to inspire advancements in medical research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile